Skip to main content

COVID-19 Vaccination Before Infection Cuts Risk for Long COVID

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 27, 2023.

By Elana Gotkine HealthDay Reporter

MONDAY, Nov. 27, 2023 -- COVID-19 vaccination before infection is associated with a reduced risk for post-COVID-19-condition (PCC), according to a study published online Nov. 22 in The BMJ.

Lisa Lundberg-Morris, from the University of Gothenburg in Sweden, and colleagues conducted a population-based cohort study to examine the effectiveness of primary COVID-19 vaccination (first two doses and first booster dose) against PCC. Data were included for all 589,722 adults with COVID-19 first registered between Dec. 27, 2020, and Feb. 9, 2022, in the two largest regions of Sweden.

Of the vaccinated individuals, 21,111; 205,650; and 72,931 received one two, and three or more doses, respectively. The researchers found that 0.4 percent of 299,692 vaccinated individuals with COVID-19 had a diagnosis of PCC during follow-up compared with 1.4 percent of 290,030 unvaccinated individuals. There was an association between COVID-19 vaccination with any number of doses before infection and a reduced risk for PCC (adjusted hazard ratio, 0.42), with vaccine effectiveness of 58 percent. Vaccine effectiveness was 21, 59, and 73 percent with one, two, and three or more doses, respectively.

"The results from this study highlight the importance of complete primary vaccination coverage against COVID-19, not only to reduce the risk of severe acute COVID-19 infection but also the burden of PCC in the population," the authors write.

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Editorial

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted November 2023

Further Support and Information on COVID-19

Read this next

Following Drop After COVID-19 Onset, Inappropriate Antibiotic Prescribing Is Up

WEDNESDAY, May 1, 2024 -- There was an initial decrease in inappropriate antibiotic prescriptions following onset of COVID-19, followed by an increase, according to a study...

Long-Term Smell, but Not Taste, Deficits Seen After COVID-19

WEDNESDAY, May 1, 2024 -- Olfactory dysfunction, especially for smell, is more common in individuals with prior COVID-19 versus individuals with no history of infection, with...

SARS-CoV-2 Vaccine Does Not Increase New-Onset Seizure Risk

TUESDAY, April 30, 2024 -- There is no risk for new-onset seizure incidence for individuals receiving a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine versus...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.